CRSP - CRISPR Therapeutics Inc Year-over-year net earnings per share growth for the last 12 months

CRISPR - graphic logo of issuer CRSP

Quarterly EPS variation on GURU.Markets demonstrates the CRISPR Therapeutics AG (CRSP) model, which relies on outsourcing production and testing to major partners to reduce costs. The 1.20 level captures the current state of profit dynamics, while the company adheres to bio-waste disposal standards. The development of innovations in oncology and cardiology allows for the effective diversification of scientific risks associated with gene editing.

crisprtx.com (CRSP) - Year-over-year earnings per one share growth for the last 12 months from 07/04/2022 to 11/18/2026

CRISPR Therapeutics AG (CRSP) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Initial company analysis:CRISPR Therapeutics AG
Manufactured product of CRISPR

Assessing the financial stability of CRISPR Therapeutics AG (CRSP) requires an analysis of capital monetization efficiency. This indicator measures the growth rate of net earnings per share, reflecting the business's ability to generate income during periods of economic growth. By examining the quarterly dynamics of earnings per share, an investor can see the actual return on investment. For CRISPR Therapeutics AG (CRSP), this metric correlates with the success of global alliances that reduce clinical trial costs.

Competing companies

TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|Year-over-year earnings per share growth for the last twelve months WGS (GeneDx)|Ultragenyx Pharmaceutical - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Beam Tx BEAM|Sarepta Therapeutics - Quarterly EPS earnings growth|Twist Bioscience (TWST) - Year-over-year net earnings per share growth for the last 12 months|TXG: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Intellia Therapeutics Inc (NTLA)|STOK (stoketherapeutics.com) - Quarterly EPS earnings growth|BLFS (BioLife Corp) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Wave Life Sciences Ltd. (WVE)|Year-over-year earnings per share growth rate for the last twelve months MAZE|sionnatx.com - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PRME|TSHA - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months uniQure Corp|meiragtx.com (MGTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months RGNX|Year-over-year net earnings per share growth for the last 12 months SLDB|Quarterly EPS earnings growth Ocugen Inc|Year-over-year earnings per share growth for the last twelve months PacBio Corp (PACB)|Year-over-year net earnings per share change for the last twelve months Benitec Corp|Quarterly EPS earnings growth DSGN (Design Therapeutics, Inc.)|Quarterly EPS earnings growth rocketpharma.com RCKT|4DMT - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Quarterly EPS earnings growth|proqr.com (PRQR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CDXS (Codexis Bio)|SGMO - Earnings per share growth in annualized terms for the last twelve months|Nautilus Biotechnology, Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Metagenomi, Inc|Precision BioSciences - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Year-over-year earnings per share growth for the last twelve months|Exicure Inc. - Year-over-year earnings per one share growth for the last 12 months|IMNN (imunon.com) - Quarterly EPS earnings growth|Phio Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)